Announcements Trials
Browse Landscape

Status

Completed 4Unknown 3Terminated 3Recruiting 3Active not recruiting 2

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Observational 3

Sponsor

Cancer Type

Gastrointestinal 7Head & Neck 4Thoracic 3Breast 3Endocrine 2NET 1Gynecologic 1CNS 1

Conditions

Lung Neoplasms 3Neoplasms 1Multiple Endocrine Neoplasia Type 2a 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Carboplatin 132Cisplatin 129Pemetrexed 114Docetaxel 81Drug Therapy 62Gefitinib 57anlotinib 55Gemcitabine 55Erlotinib Hydrochloride 55Radiotherapy 48Bevacizumab 48pembrolizumab 47Paclitaxel 47Etoposide 44apatinib 42icotinib 41camrelizumab 39osimertinib 36Nivolumab 33Vinorelbine 31Radiosurgery 30sintilimab 29durvalumab 25aumolertinib 25endostar protein 24atezolizumab 22Endostatins 22toripalimab 19Blood Specimen Collection 19tislelizumab 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × Liquid Biopsy × Thoracic × Clear all
NCT06081270 2023-10-13

MUT-ONC

University of Milano Bicocca

Unknown
20 enrolled
EndocrineThoracic

Lung Neoplasms, Multiple Endocrine Neoplasia Type 2a

NCT05641870 2022-12-12

Molecular Profiling and Dynamic Changes of ctDNA in Unresectable Locally Advanced NSCLC

Parc de Salut Mar

Unknown
80 enrolled
Thoracic

Lung Neoplasms

NCT05254132 2022-02-24

SALMON

OncoRadiomics

Unknown
1,000 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡